期刊文献+

外周血标本检测EGFR基因突变的操作体会

下载PDF
导出
摘要 本文旨在介绍外周血样品应用扩增阻滞突变系统(ARMS法)检测EGFR基因突变的操作流程,以及在实际操作中可能遇到的问题,并对外周血检测EGFR基因的应用和优缺点进行总结。1材料与方法1.1材料1.1.1标本收集中日友好医院2015-08~11间送检的10例外周血样品,其中男性8例,女性2例,年龄45~77岁,平均年龄60.5岁。每例样品采血10 ml,EDTA抗凝。
作者 王也 笪冀平
出处 《诊断病理学杂志》 CSCD 2016年第6期471-473,共3页 Chinese Journal of Diagnostic Pathology
  • 相关文献

参考文献10

  • 1Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al. Erlotinib in previously treated non-small cell lung cancer [ J ]. N Engl J Med, 2005 ;353:123 - 132.
  • 2Kris MG, Natale RB, Herbst RS, et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial [ J]. JAMA, 2003 ;290:2149 - 2158.
  • 3Kimura H, Suminoe M, Kasahara K, et al. Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA) [ J]. Br J Cancer, 2007 ;97:778 -784.
  • 4Jian G, Songwen Z, Ling Z, et al. Prediction of epidermal growth factor receptor mutations in the plasma/pleural suffusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer [ J]. J Cancer Res Clin Oncol, 2010;136(9) :1341 - 1347.
  • 5Liu X, Lu Y, Zhu G, et al. Classification of epidermal growth factor receptor gene mutation status using serum proteomic profiling predicts tumor response in patients woth stage IIIB or IV non-small cell lung cancer [J ]. J Clin Pathol, 2013;66 (12) : 1065 - 1069.
  • 6Ren S, Wu C, Li X, et al. Detection of EGFR mutation of serum circulating DNA [J]. J Clin Oncol, 2014,32:5s.
  • 7Kim ST, Jung I-l'Y, Sung JS, et al. Can serum be used for analyzing the EGFR mutation status in patients with advanced non-small cell lung cancer [J]?. Am J Clin Oncol, 2013;36(1) :57 -63.
  • 8Zheng D, Ye X, Sun Y, et al. Noninvasive monitoring of dynamics of a acquired EGFR-T'/90M mutation and discovery of its heterogeneity in patients with advanced NSCLC treated with EGFR-TKI [ R]. J Clin 0ncol,2014,32:5s.
  • 9Oxnard GR, Paweletz CP, Kuang Y, et al. Noninvasive detection of response and resistance in EGFR-mntant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA [J]. Clin Cancer Res, 2014;20(6) :1698 - 1705.
  • 10Janne PA, Ramalingam SS, Yang JCH, et al. Clinical activity of the mutant-selective EGFR inhibitor AZD9291 in patients (pts) with EGFR inhibitor-resistant non-small cell lung cancer (NSCLC) [ J]. J Clin Oncol, 2014,32:5s.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部